HC Wainwright & Co. Initiates Coverage On Finch Therapeutics Group with Buy Rating, Announces Price Target of $17
HC Wainwright & Co. Initiates Coverage On Finch Therapeutics Group with Buy Rating, Announces Price Target of $17
HC Wainwright & Co.以买入评级启动对Finch Therapeutics集团的报道,宣布目标股价为17美元
HC Wainwright & Co. analyst Vernon Bernardino initiates coverage on Finch Therapeutics Group (NASDAQ:FNCH) with a Buy rating and announces Price Target of $17.
HC Wainwright & Co. 分析师弗农·贝纳迪诺以买入评级开始报道芬奇治疗集团(纳斯达克股票代码:FNCH),并宣布目标股价为17美元。